Companies: 10,795·Total market cap: $144.5T
Neovasc Inc.

Neovasc Inc.

NVCNNASDAQHealthcare
$30.03
+$0.00(+0.00%)
Market Cap$82859377
P/E Ratio
52W High$30.07
52W Low$4.585
Overview

Neovasc Inc.(NVCN)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · NVCN · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2022-122021-122020-122019-122018-12
Revenue
Revenue$3.81M$2.55M$1.96M$2.09M$1.75M
Cost of Revenue$0.77M$0.56M$0.45M$0.46M$0.37M
Gross Profit$3.03M$1.99M$1.51M$1.63M$1.38M
Gross Margin %(computed)79.66%78.19%77.20%78.09%79.06%
Operating Expenses
R&D Expenses$17.54M$15.45M$20.40M$20.02M$16.06M
G&A Expenses$15.64M$14.66M$13.21M$9.03M$12.33M
Total Operating Expenses$36.77M$33.10M$36.39M$31.57M$32.55M
Operating Income($33.74M)($31.11M)($34.88M)($29.94M)($31.17M)
Operating Margin %(computed)-886.75%
Interest Income$0.47M$0.55M$1.39M$0.18M$0.18M
Interest Expense$1.52M$0.63M$1.04M$0.13M$0.00M
Income Before Tax($41.18M)($24.80M)($29.22M)($35.10M)($107.94M)
Income Tax Expense$0.02M$0.09M($0.52M)$0.03M$0.11M
Net Income($41.20M)($24.89M)($28.70M)($35.13M)($108.04M)
Net Margin %(computed)-977.04%
Per Share & EBITDA
EPS (Basic)$-15.07$-9.88$-43.04$-134.88$-1907.54
Wtd Avg Shares2.73M2.52M0.67M0.26M0.06M
EBITDA($37.07M)($39.63M)($36.22M)($29.11M)($0.73M)
EBITDA Margin %(computed)-974.20%-41.65%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Neovasc Inc.

关于Neovasc Inc.(NVCN)损益表

Neovasc Inc.(NVCN)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,NVCN实现营收$0.00B,毛利润$0.00B(毛利率79.66%),净利润($0.04B)(净利率-1082.90%)。

常见问题

NVCN · 4 问

Neovasc Inc.(NVCN)2022财年营收为$0.00B,同比up49.4%。

NVCN revenueNVCN salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09